Zobrazeno 1 - 10
of 51
pro vyhledávání: '"Don Luo"'
Autor:
Sandra De Meyer, Zobair M. Younossi, Gaston Picchio, R. Focaccia, Stuart K. Roberts, Don Luo, Andrzej Horban, Paul J. Pockros, Martyn Botfield, Maria Beumont, Eric Lawitz, Stefan Zeuzem, Pietro Andreone, Stanislas Pol, Jeroen Aerssens, Rolf van Heeswijk, Graham R. Foster
Publikováno v:
Journal of Hepatology. 58:883-889
Background & Aims Nucleotide polymorphisms upstream of the interleukin 28B ( IL28B ) gene are strongly associated with hepatitis C virus (HCV) clearance in treatment-naive patients treated with peginterferon/ribavirin (PegIFN/RBV). This subanalysis o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bbc35585954b2af5702dc93d33bb3201
https://doi.org/10.1016/j.jhep.2012.12.023
https://doi.org/10.1016/j.jhep.2012.12.023
Publikováno v:
The American Journal of Cardiology. 100:445-449
The increased cardiovascular risk associated with hypertriglyceridemia is thought to be due in part to high levels of triglyceride (TG)-rich lipoproteins and small dense low-density lipoprotein (LDL). In this post hoc analysis, effects of increasing
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dc52ee629c478ac7651d2875875cebbe
https://doi.org/10.1016/j.amjcard.2007.03.043
https://doi.org/10.1016/j.amjcard.2007.03.043
Autor:
Prakash Deedwania, C. Noel Bairey Merz, Dan Tzivoni, Peter Stone, Pamela Ouyang, Don Luo, Ryszard Piotrowicz, Peter L. Thompson, James H. Stein, Juan Cosin-Aguilar, Karin Schenck-Gustafsson, Philippe Sellier, Nevres Koylan
Publikováno v:
Circulation. 115:700-707
Background— Clinical trials have demonstrated that, compared with placebo, intensive statin therapy reduces ischemia in patients with acute coronary syndromes and in patients with stable coronary artery disease. However, no studies to date have ass
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a5e395f395386ed22511563afaf8767c
https://doi.org/10.1161/circulationaha.106.654756
https://doi.org/10.1161/circulationaha.106.654756
Autor:
I. Lonjon-Domanec, Sandra De Meyer, Maria Beumont, Stefan Zeuzem, Don Luo, Stuart K. Roberts, Pietro Andreone, Shelley George, Paul J. Pockros, Graham R. Foster, Moisés Diago, Stanislas Pol, Eric Lawitz, Zobair M. Younossi, Gaston Picchio
BACKGROUND & AIMS: For hepatitis C virus (HCV)-infected patients who have not responded to previous PegIFN/ribavirin treatment, it is unclear whether subsequent direct-acting antiviral therapy outcomes are better predicted by prior treatment response
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::56f0065bcd88644dcd98fc8186c3e469
http://hdl.handle.net/11585/394989
http://hdl.handle.net/11585/394989
Autor:
John H. Fuller, Shona Livingstone, Helen M. Colhoun, David A. DeMicco, D. John Betteridge, H. Andrew W. Neil, Graham A. Hitman, Paul N. Durrington, Cards Investigators, Don Luo
Publikováno v:
Diabetes Care. 29:2378-2384
OBJECTIVE—Rates of cardiovascular disease are highest in the elderly. Lipid-lowering statin therapy reduces the proportional risk as effectively in older patients as in younger individuals; however, limited data are available for elderly patients w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e4f44244028ec14b4af8ad0d74dc95c1
https://doi.org/10.2337/dc06-0872
https://doi.org/10.2337/dc06-0872
Publikováno v:
The American Journal of Cardiology. 97:61-67
Atorvastatin has been shown to reduce coronary events and revascularization procedures in patients with multiple risk factors for coronary heart disease. Recent studies with atorvastatin 80 mg support the overall safety of this dose during long-term
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d0361883203896aa76303596c284b467
https://doi.org/10.1016/j.amjcard.2005.07.108
https://doi.org/10.1016/j.amjcard.2005.07.108
Autor:
Gaston Picchio, Leif Bengtsson, Tara L. Kieffer, Nathalie Adda, Linda Gritz, Ira M. Jacobson, Doug J. Bartels, Robert S. Kauffman, Frank Tomaka, Don Luo
Publikováno v:
Clinical Gastroenterology and Hepatology. 11:193-195
For patients treated with telaprevir, peginterferon, and ribavirin, futility rules have been developed to prevent needless drug exposure and minimize development of drug-resistant variants for patients who have little or no chance of achieving a sust
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e27f7e6698a32eb8321a3f02c67c331d
https://doi.org/10.1016/j.cgh.2012.10.045
https://doi.org/10.1016/j.cgh.2012.10.045
Autor:
Gregory W. Whiting, Thomas C. Chalmers, Jean-Francois Caubet, Donna Niedzwiecki, Christopher H. Schmid, Susan D. Ross, Douglas Cory, Don Luo, William B. Stason
Publikováno v:
Hypertension. 33:24-31
Abstract —Our objective was to compare cardiovascular event rates in patients with stable angina receiving nifedipine as monotherapy or combination therapy and in active drug controls. A MEDLARS search of published articles from 1966 to 1995 in Eng
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::66f1f159878ccb7ee08a0ead19746170
https://doi.org/10.1161/01.hyp.33.1.24
https://doi.org/10.1161/01.hyp.33.1.24
Autor:
H Andrew W, Neil, David A, DeMicco, Don, Luo, D John, Betteridge, Helen M, Colhoun, Paul N, Durrington, Shona J, Livingstone, John H, Fuller, Graham A, Hitman
Publikováno v:
Diabetes care. 29(11)
Rates of cardiovascular disease are highest in the elderly. Lipid-lowering statin therapy reduces the proportional risk as effectively in older patients as in younger individuals; however, limited data are available for elderly patients with type 2 d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::25c65d36fe9b01481c3a2166c7747a15
https://pubmed.ncbi.nlm.nih.gov/17065671
https://pubmed.ncbi.nlm.nih.gov/17065671
Publikováno v:
The American journal of cardiology. 99(5)
After acute coronary syndromes (ACSs), older patients are particularly susceptible to early complications, including death and recurrent ACS. Lipid management guidelines do not differentiate elderly from younger patients, and lack of evidence for sta
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8da5b490ff608fb036b2a375ba689ea4
https://pubmed.ncbi.nlm.nih.gov/17317362
https://pubmed.ncbi.nlm.nih.gov/17317362